FI844644L - Framstaellningsfoerfarande foer indanylderivat och deras anvaendning. - Google Patents

Framstaellningsfoerfarande foer indanylderivat och deras anvaendning.

Info

Publication number
FI844644L
FI844644L FI844644A FI844644A FI844644L FI 844644 L FI844644 L FI 844644L FI 844644 A FI844644 A FI 844644A FI 844644 A FI844644 A FI 844644A FI 844644 L FI844644 L FI 844644L
Authority
FI
Finland
Prior art keywords
indanylderivat
och deras
deras anvaendning
framstaellningsfoerfarande foer
framstaellningsfoerfarande
Prior art date
Application number
FI844644A
Other languages
English (en)
Other versions
FI844644A0 (fi
FI77893B (fi
FI77893C (fi
Inventor
Karl Petzoldt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI844644A0 publication Critical patent/FI844644A0/fi
Publication of FI844644L publication Critical patent/FI844644L/fi
Publication of FI77893B publication Critical patent/FI77893B/fi
Application granted granted Critical
Publication of FI77893C publication Critical patent/FI77893C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/02Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/66Aspergillus
    • C12R2001/685Aspergillus niger

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI844644A 1983-11-28 1984-11-27 Foerfarande foer framstaellning av indanylderivat. FI77893C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833343331 DE3343331A1 (de) 1983-11-28 1983-11-28 Verfahren zur herstellung von indanyl-derivaten und deren verwendung
DE3343331 1983-11-28

Publications (4)

Publication Number Publication Date
FI844644A0 FI844644A0 (fi) 1984-11-27
FI844644L true FI844644L (fi) 1985-05-29
FI77893B FI77893B (fi) 1989-01-31
FI77893C FI77893C (fi) 1989-05-10

Family

ID=6215683

Family Applications (1)

Application Number Title Priority Date Filing Date
FI844644A FI77893C (fi) 1983-11-28 1984-11-27 Foerfarande foer framstaellning av indanylderivat.

Country Status (18)

Country Link
US (1) US4696948A (fi)
EP (1) EP0143403B1 (fi)
JP (1) JPS60199394A (fi)
AT (1) ATE62511T1 (fi)
AU (1) AU568701B2 (fi)
CA (1) CA1245589A (fi)
CS (1) CS244844B2 (fi)
DD (1) DD229153A5 (fi)
DE (2) DE3343331A1 (fi)
DK (1) DK561484A (fi)
ES (1) ES537971A0 (fi)
FI (1) FI77893C (fi)
GR (1) GR81056B (fi)
HU (1) HU193238B (fi)
IL (1) IL73657A (fi)
NO (1) NO164845C (fi)
PT (1) PT79556B (fi)
ZA (1) ZA849287B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753725B2 (ja) * 1987-10-08 1995-06-07 富山化学工業株式会社 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
US5409944A (en) * 1993-03-12 1995-04-25 Merck Frosst Canada, Inc. Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
US5500359A (en) * 1993-09-27 1996-03-19 Solvay Enzymes, Inc. Method for producing a therapeautic composition for papillomavirus-induced tumors with aspergillus niger
WO1996023786A1 (en) * 1995-01-31 1996-08-08 Merck Frosst Canada Inc. 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965279D1 (en) * 1978-07-27 1983-06-01 Schering Ag Indanyl derivatives, process for their preparation and pharmaceutical compositions containing these compounds
DE3103372A1 (de) * 1981-01-27 1982-09-02 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue indanyl-derivate, ihre herstellung und verwendung
DE3208079A1 (de) * 1982-03-04 1983-09-08 Schering AG, 1000 Berlin und 4709 Bergkamen Neue indanyl-derivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
CA1245589A (en) 1988-11-29
DK561484A (da) 1985-05-29
EP0143403B1 (de) 1991-04-10
JPS60199394A (ja) 1985-10-08
CS244844B2 (en) 1986-08-14
PT79556A (de) 1984-12-01
ATE62511T1 (de) 1991-04-15
AU568701B2 (en) 1988-01-07
FI844644A0 (fi) 1984-11-27
DK561484D0 (da) 1984-11-27
DD229153A5 (de) 1985-10-30
EP0143403A2 (de) 1985-06-05
HU193238B (en) 1987-08-28
PT79556B (de) 1986-09-15
FI77893B (fi) 1989-01-31
ZA849287B (en) 1985-07-31
IL73657A0 (en) 1985-02-28
ES8600736A1 (es) 1985-11-01
EP0143403A3 (en) 1987-07-22
DE3343331A1 (de) 1985-06-05
ES537971A0 (es) 1985-11-01
NO164845B (no) 1990-08-13
NO844702L (no) 1985-05-29
AU3584484A (en) 1985-06-06
US4696948A (en) 1987-09-29
JPH054069B2 (fi) 1993-01-19
DE3484422D1 (de) 1991-05-16
NO164845C (no) 1990-11-21
HUT36499A (en) 1985-09-30
FI77893C (fi) 1989-05-10
IL73657A (en) 1987-10-30
GR81056B (en) 1985-03-26

Similar Documents

Publication Publication Date Title
NO972304L (no) Vitamin D3-analoger
FI861506A (fi) Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra).
FI820529L (fi) Bispidinderivat, deras framstaellning och dessa innehaollande laekemedel
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
FI844644L (fi) Framstaellningsfoerfarande foer indanylderivat och deras anvaendning.
AU562515B2 (en) Pyridinecarbinols
PT86552A (de) Gama-glutamyl-transpeptidase deren herstellung und deren verwendung
ATE61800T1 (de) 1-phenylimidazolcarbonsaeureamide, ihre herstellung sowie ihre verwendung als wachstumsregulatoren.
SE7709195L (sv) Fungicid
ES460807A1 (es) Procedimiento para la produccion de compuestos de isoindoli-nona.
ATE17485T1 (de) 3,7a-diazacyclohepta(j,k)fluorenderivate, ihre herstellung und ihre therapeutische verwendung.
SE8402361D0 (sv) Novel acylaminophenol derivatives
IL57555A0 (en) 1-phenyl-3-benzoyl-urea derivatives,their production and their use as insecticides
FI811201L (fi) 4-hydroxi-1,2-benzisotiazol-3(2h)-on-1,1-dioxid deras salter deras framstaellning och anvaendning
ATE17945T1 (de) 7-phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepin , ihre herstellung und verwendung.
GB2006751A (en) N-(1,3,4-Thiadiazol-2-yl)benzamides
SE8205655D0 (sv) 2,5-anhydro-d-mannitol and esters thereof
AU529684B2 (en) Organic compounds
ATE8789T1 (de) Neue kortikoide, ihre herstellung und verwendung.
SU669683A1 (ru) Галогенпроизводные 2-бензилиденгидразиноциклогексено [d]тиазола, обладающие акарицидной активностью

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: SCHERING AKTIENGESELLSCHAFT